Literature DB >> 26341161

Cardiac MRI-confirmed mesalamine-induced myocarditis.

William L Baker1, Whitney J Saulsberry1, Kaitlyn Elliott1, Matthew W Parker2.   

Abstract

A 38-year-old Caucasian man with a medical history significant for inflammatory bowel disease (IBD) and mesalamine use presented to the emergency department with stabbing, pleuritic, substernal chest pain over the previous 2 days. Findings of leucocytosis, elevated cardiac enzymes and inflammatory markers, T-wave or ST-segment abnormalities and left ventricular systolic dysfunction suggested mesalamine-induced myocarditis. However, a cardiac MRI confirmed the diagnosis. Signs and symptoms improved within days of withdrawal of mesalamine, and initiation of corticosteroids and follow-up studies within the next year were unremarkable. Importantly, the diagnosis of mesalamine-induced myocarditis confirmed via cardiac MRI is a step rarely performed in published cases. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26341161      PMCID: PMC4567714          DOI: 10.1136/bcr-2015-210689

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Recurrence of myocarditis after mesalazine treatment for ulcerative colitis: a case report.

Authors:  Tony Sabatini; Alida Filippini; Francesca Nicosia; Stefania Preti; Maurizio Bertoli
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

2.  Mesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.

Authors:  Carlos Galvão Braga; Juliana Martins; Carina Arantes; Vítor Ramos; Catarina Vieira; Alberto Salgado; Sónia Magalhães; Adelino Correia
Journal:  Rev Port Cardiol       Date:  2013-08-30       Impact factor: 1.374

3.  Myocarditis by mesalazine with cardiac magnetic resonance imaging.

Authors:  Luis García-Ferrer; Jordi Estornell; Victor Palanca
Journal:  Eur Heart J       Date:  2009-01-24       Impact factor: 29.983

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 5.  Possible mesalamine-induced pericarditis: case report and literature review.

Authors:  Robert A Waite; Jennifer M Malinowski
Journal:  Pharmacotherapy       Date:  2002-03       Impact factor: 4.705

6.  Mesalamine-induced myocarditis.

Authors:  Olivier Merceron; Clement Bailly; Antoine Khalil; Florence Pontnau; Nadjib Hammoudi; Richard Dorent; Pierre-Louis Michel
Journal:  Cardiol Res Pract       Date:  2010-09-13       Impact factor: 1.866

7.  A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.

Authors:  Kristopher W Cummings; Sanjeev Bhalla; Cylen Javidan-Nejad; Andrew J Bierhals; Fernando R Gutierrez; Pamela K Woodard
Journal:  Radiographics       Date:  2009 Jan-Feb       Impact factor: 5.333

  7 in total
  1 in total

1.  A Rare Case of Mesalazine-Induced Acute Myocarditis in a 19-Year-Old Female With Ulcerative Colitis.

Authors:  Abuobeida Ali; Aravind Sunderavel Kumaravel Kanagavelu; Abdulhameed Rahimi; Zia Mehmood; Adeel B Tariq; Tapas Das; Ali Elmdaah
Journal:  Cureus       Date:  2021-11-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.